Allogeneic stem cell therapy allows "off the shelf" cells to be used in therapy, rather than having to take cells from each individual patient, allowing a relatively fast and inexpensive therapy.

Instead, we're recruiting healthy soldiers from disease-free, well donors and equipping them with special targeting systems ...

If you’re like me and have also pulled almost everything out of your fridge to find your go-to salad dressing or that one ...

German regulatory agency, the Paul Ehrlich Institute, granted approval to expand the INVISE Phase 1 clinical trial evaluating INT2104 for the treatment of B-cell malignancies to Europe The first ...

Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) --. (NASDAQ: ...

Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies ... and jointly develop T-cell therapy candidates against them.

RION, a clinical-stage regenerative medicine company revolutionizing healthcare through its exosome-based technology, announced today that its Co-Founder, Dr. Atta Behfar, will present at the 43rd ...

Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...

Khrystyne and Nic Jaspers moved into a 750-square-foot New York apartment when they were expecting their second child.

The ability to suppress NK-mediated rejection is a key advancement in enabling off-the-shelf CAR-T therapy, supporting the potential to overcome scalability, logistics and cost challenges ...

In "Beyond Anxiety," Martha Beck argues that discovering your creative calling is the antidote to an anxious existence.